Home/Keltic Pharma Therapeutics/Professor Andrew Jameson
PA

Professor Andrew Jameson

Co-Founder, Chemical Biology Expert, Architect of PEPSMOL©

Keltic Pharma Therapeutics

Keltic Pharma Therapeutics Pipeline

DrugIndicationPhase
Severe Asthma (FFA4 receptor)Severe AsthmaPre-clinical
MalariaMalariaPre-clinical
NeurodegenerationAlzheimer's DiseasePre-clinical
SchizophreniaSchizophreniaPre-clinical